All companion diagnostic (CDx) testing below is performed at LMC Pathology Services, a Sonic Healthcare Anatomic Pathology Practice, and a leading pathology services and cancer diagnostic laboratory. LMC is focused on delivering accurate diagnostic, prognostic and therapeutic information. Our goal is to serve every community with advanced medicine and premier healthcare services. Our expert pathology team is prepared to work collaboratively with physicians to provide meaningful testing results, which may translate to more effective patient treatment options. LMC Pathology Services integrates the highest quality of diagnostic services, professional consultation, and expert analysis resulting in quality patient care.
FOLR1 (FOLR1-2.1)
First FDA-approved immunohistochemistry companion diagnostic test that detects the Folate Receptor (FOLR1) biomarker in patients with epithelial ovarian cancer (EOC).
MMR RxDx Panel
First FDA-approved immunohistochemical companion diagnostic test to identify endometrial cancer patients eligible for immunotherapy.
PD-L1
FDA-approved, indication specific PD-L1 stains for melanoma, bladder, lung, breast, gastro-esophageal, cervical, and head & neck cancers.
Companion Diagnostic Ordering Information
Specimen Requirements
Specimen: |
Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides |
Volume: |
At least two unstained slides sectioned at 4 microns, less than 60 days since sectioning and if stored at 15°C to 30°C. Four slides are ideal MMR testing requires at least 6 slides |
Minimum Volume: |
Two unstained slides at 4 microns less than two months since sectioning if stored at 15°C to 30°C MMR testing requires at least 6 slides |
Container: |
Paraffin block or unstained positively-charged slides |
Collection: |
Paraffin block or unstained slides sectioned if stored at 15°C to 30°C for two months |
Storage Instructions: |
Refrigerate |
Causes for Rejection: |
Slides sectioned greater than two months prior to test request and not stored at 15°C to 30°C |